The optimal glycemic target in critically ill patients: an updated network meta-analysis
Aiko Tanaka, Tomoaki Yatabe, Tomohiro Suhara, Moritoki Egi
Abstract
Acute glycemic control significantly affects the clinical outcomes of critically ill patients. This updated network meta-analysis examines the benefits and harms of four target blood glucose levels (< 110, 110-144, 144-180, and > 180 mg/dL). Analyzing data of 27,541 patients from 37 trials, the surface under the cumulative ranking curve for mortality and hypoglycemia was highest at a target blood glucose level of 144-180 mg/dL, while for infection and acute kidney injury at 110-144 mg/dL. Further evidence is needed to determine whether 110-144 or 144-180 mg/dL is superior as an optimal glucose target, considering prioritized outcomes.
Topics & Concepts
GlycemicMedicineHypoglycemiaCritically illMeta-analysisIntensive care medicineInternal medicineInsulinHyperglycemia and glycemic control in critically ill and hospitalized patientsElectrolyte and hormonal disordersSepsis Diagnosis and Treatment